AMD
Clinical trials for AMD explained in plain language.
Never miss a new study
Get alerted when new AMD trials appear
Sign up with your email to follow new studies for AMD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Time gene therapy could free wet AMD patients from lifelong eye injections
Disease control OngoingThis study tests a one-time gene therapy called RGX-314 for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if a single treatment can control the disease and reduce the need for repeated eye injections. About 671 adults a…
Matched conditions: AMD
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Researchers track Real-Life results of eye disease treatments
Knowledge-focused OngoingThis study looks at how patients with chronic eye diseases like glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy are doing after their treatments. Researchers will follow 300 adults who had an eye procedure in the last 6 months to measure changes in eye …
Matched conditions: AMD
Sponsor: Interstat LLC • Aim: Knowledge-focused
Last updated May 04, 2026 16:21 UTC